Stocks and Investing
Stocks and Investing
Wed, December 16, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
John Morrison Maintained (ZNTL) at Buy with Increased Target to $75 on, Dec 16th, 2020
John Morrison of Morgan Stanley, Maintained "Zentalis Pharmaceuticals, Inc." (ZNTL) at Buy with Increased Target from $50 to $75 on, Dec 16th, 2020.
John has made no other calls on ZNTL in the last 4 months.
There are 2 other peers that have a rating on ZNTL. Out of the 2 peers that are also analyzing ZNTL, 0 agree with John's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with John
- Eliana Merle of "Cantor Fitzgerald" Initiated at Buy and Held Target at $44 on, Tuesday, September 29th, 2020
- Andrew Fein of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $43 on, Thursday, August 27th, 2020